Suppr超能文献

肥胖、步行速度与 COVID-19 重症和死亡率风险:英国生物库分析。

Obesity, walking pace and risk of severe COVID-19 and mortality: analysis of UK Biobank.

机构信息

Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, UK.

National Institute for Health Research (NIHR) Leicester Biomedical Research Centre (BRC), NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.

出版信息

Int J Obes (Lond). 2021 May;45(5):1155-1159. doi: 10.1038/s41366-021-00771-z. Epub 2021 Feb 26.

Abstract

Obesity is an emerging risk factor for coronavirus disease-2019 (COVID-19). Simple measures of physical fitness, such as self-reported walking pace, may also be important risk markers. This analysis includes 412,596 UK Biobank participants with linked COVID-19 data (median age at linkage = 68 years, obese = 24%, median number of comorbidities = 1). As of August 24th 2020, there were 1001 cases of severe (in-hospital) disease and 336 COVID-19 deaths. Compared to normal weight individuals, the adjusted odds ratio (OR) of severe COVID-19 in overweight and obese individuals was 1.26 (1.07, 1.48) and 1.49 (1.25, 1.79), respectively. For COVID-19 mortality, the ORs were 1.19 (0.88, 161) and 1.82 (1.33, 2.49), respectively. Compared to those with a brisk walking pace, the OR of severe COVID-19 for steady/average and slow walkers was 1.13 (0.98, 1.31) and 1.88 (1.53, 2.31), respectively. For COVID-19 mortality, the ORs were 1.44 (1.10, 1.90) and 1.83 (1.26, 2.65), respectively. Slow walkers had the highest risk regardless of obesity status. For example, compared to normal weight brisk walkers, the OR of severe disease and COVID-19 mortality in normal weight slow walkers was 2.42 (1.53, 3.84) and 3.75 (1.61, 8.70), respectively. Self-reported slow walkers appear to be a high-risk group for severe COVID-19 outcomes independent of obesity.

摘要

肥胖是 2019 年冠状病毒病(COVID-19)的一个新出现的危险因素。身体活动能力的简单测量指标,如自我报告的步行速度,也可能是重要的风险标志物。本分析包括 412596 名有 COVID-19 相关数据链接的英国生物银行参与者(链接时的中位年龄为 68 岁,肥胖者占 24%,中位共病数为 1)。截至 2020 年 8 月 24 日,有 1001 例严重(住院)疾病和 336 例 COVID-19 死亡。与正常体重者相比,超重和肥胖者患严重 COVID-19 的校正比值比(OR)分别为 1.26(1.07,1.48)和 1.49(1.25,1.79)。对于 COVID-19 死亡率,比值比分别为 1.19(0.88,161)和 1.82(1.33,2.49)。与快步走者相比,中速/慢速行走者患严重 COVID-19 的 OR 分别为 1.13(0.98,1.31)和 1.88(1.53,2.31)。对于 COVID-19 死亡率,比值比分别为 1.44(1.10,1.90)和 1.83(1.26,2.65)。无论肥胖状况如何,慢速行走者的风险最高。例如,与正常体重快步走者相比,正常体重慢速行走者患严重疾病和 COVID-19 死亡率的比值比分别为 2.42(1.53,3.84)和 3.75(1.61,8.70)。自我报告的慢速行走者似乎是 COVID-19 严重后果的高危人群,与肥胖无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5c35/7909370/95af2e57114d/41366_2021_771_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验